Literature DB >> 27521092

Exercise-induced Ventricular Tachycardia/Ventricular Fibrillation in the Normal Heart: Risk Stratification and Management.

Yoav Michowitz1, Sami Viskin2, Raphael Rosso1.   

Abstract

Exercise-induced ventricular tachycardia (VT) rarely occurs in the absence of organic heart disease. Idiopathic monomorphic VT has an excellent prognosis. The main aspect of the risk stratification process is recognizing subtle forms of organic heart disease, particularly arrhythmogenic right ventricular cardiomyopathy. Exercise-induced polymorphic VT is potentially malignant. Exercise-induced polymorphic VT has also been seen in mitral valve prolapse. Some patients with stable coronary disease, and even healthy athletes, sometimes have short bursts of polymorphic VT during exercise tests but these arrhythmias are usually not reproducible during repeated testing and have unknown long-term clinical significance.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmogenic right ventricular cardiomyopathy; Catecholaminergic polymorphic ventricular tachycardia; Exercise; Mitral valve prolapse; Ventricular fibrillation; Ventricular tachycardia

Mesh:

Year:  2016        PMID: 27521092     DOI: 10.1016/j.ccep.2016.04.008

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  3 in total

Review 1.  Management of Arrhythmias in Athletes: Atrial Fibrillation, Premature Ventricular Contractions, and Ventricular Tachycardia.

Authors:  Ernest Lai; Eugene H Chung
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-10-09

2.  Exercise-Induced Sustained Ventricular Tachycardia without Structural Heart Disease: A Case Report.

Authors:  Michelle Audrey Darmadi; Axel Duval; Hanaa Khadraoui; Alberto N Romero; Blanca Simon; Justyna Watkowska; Henock Saint-Jacques
Journal:  Am J Case Rep       Date:  2020-12-10

Review 3.  Idiopathic Polymorphic Ventricular Tachycardia: a "Benign Disease" with a Touch of Bad Luck?

Authors:  Sami Viskin
Journal:  Korean Circ J       Date:  2017-05-25       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.